Crescendo Biologics Ltd
CAMBRIDGE, England, September 29, 2010 - Crescendo Biologics Limited (Crescendo) today announces it has
established a colony of engineered mice completely devoid of endogenous
antibody polypeptides.
CAMBRIDGE, England, January 8 - Crescendo Biologics ("Crescendo") today announces the
appointment of Clive Dix as Chairman.
CAMBRIDGE, England - Crescendo Biologics ("Crescendo") today announces it has raised GBP4.5 million in a seed-funding round to advance the development of its fragment antibody technology platforms.
